TBI remains a major cause of death and long-term neurological disability worldwide, yet effective treatments for secondary ...

Inflammation plays a critical role in both acute and long term SARS-CoV-2 infection, as well as many of the most serious chronic diseases, such as Alzheimer’s, type 2 diabetes, and atherosclerosis.

BioAge Labs (NASDAQ:BIOA) used a presentation at the 25th Annual Needham Virtual Healthcare Conference to outline near-term clinical catalysts for its lead NLRP3 inflammasome inhibitor and provide ...

This work was supported by grants from the National Natural Science Foundation of China (Nos. 82471497, 82311530117, and ...

In a recent study published in the Molecular Psychiatry journal, researchers assessed the role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the NLR family pyrin domain containing ...

A Signaling Nexus for Both Good and Ill, It’s Pathways of Pathogenic and Therapeutic Importance Are Still Being Identified A recent paradigm shift in medicine started with the finding that several ...

A novel oral molecule significantly reduced inflammatory markers linked to development of arteriosclerotic cardiovascular ...

A study from Texas A&M University suggests a nasal spray could combat age-related cognitive decline by reducing brain ...

NEWTON, Mass.--(BUSINESS WIRE)--Inflammasome Therapeutics (https://www.inflam.com/), a clinical-stage biotech company developing novel, first-in-class dual ...

First-in-class clinical trial in dry AMD with new drug specifically designed to inhibit inflammasome activation in the eye and to be administered locally via a newly designed sustained release implant ...